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1. Introduction 
1.1. Outlines 
- Role of endoscopy in infertility. Microsurgical principles, reconstructive concept. 
- Can endoscopy omit ART? 
- Endoscopy Vs ART 
- Advantages of ART over Endoscopy 
- Fertility enhancing procedures: 
 Laparoscopic adnexal surgery. 
 Salpingoscopy 
 Hysteroscopy 
- Endoscopy prior to ART (routine hysteroscopy, role of laparoscopy (tubes with or 
withour hydrosalpnix and paratubal cysts, endometrioma). 
- Endoscopically-assisted ART. 
- Endoscopy for recurrent implantation failure. 
- Future of endoscopy in the era of ART and keynote points. 
2. Current approaches for infertility management 
In modern practice, three schools are competitors for infertility management, namely 
expectant, endoscopic and assisted reproductive techniques (ART) approaches. There are no 
RCTs that compare the effectiveness of surgery againsteither IVF or expectant management. 
The following table demonstrates pros and cons of each approach (1).  
2.1. Rationale of expectant therapy 
Any treatment should be compared to expectant therapy. 
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Table 1. Lines of infertility management 
2.2. Drawbacks of the expectant therapy 
 No strict criteria on which to base management decisions.  
 Hence, the likelihood of spontaneous pregnancy for each individual couple must be 
weighed against the potential benefits or risks of interventional treatment.  
2.3. Is surgery better than IVF? 
Logicstudies: Microsurgical reversal of sterilization is a highly cost-effective strategy when 
compared with IVF for women aged 40 years and above (2). 
Illogic studies: some over enthusiastic studies demonstrated that endoscopy is much 
better than ART. In a bizarre study, Marana et al. (3) included 43 patientsand subjected 
them to diagnostic or operative laparoscopy. Nine of themwith submucous-intramural or 
multiple intramural fibroids underwent miomectomy by minilaparotomy following 
hysteroscopy and chromopertubation. The mean length of follow- up was 49 months 
(range: 11 to 118 months). They reported a very high pregnancy rate as 61 became 
pregnant (40%).  
ARTEndoscopic  
management
Expectant 
treatment
-Time saving
Excellent results
-Restores normal 
anatomy.
-Enhances natural 
pregnancy.
-Long-term results
Safe 
cheap
Advantages
-Stress
- Expensive
- Risky
-OHSS
-Unpredictable 
outcome
- Per trial result.
- expensive
-additional 
specialist training 
-- experience 
-adverse effects 
(including ectopic
pregnancies), and 
operative risks.
-Unpredictable 
outcome
Anxiety
Unpredictable 
outcome
Disadvantages
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2.4. Advantages of laparoscopy over ART 
 Excellent results.  
 Long-lasting efficacy. 
 Reconstructive concept. 
 Physically and psychologically sound patient. 
Tubal reconstructive surgery remains an important option for many couples and surgery 
should be the first line approach for a correct diagnosis and treatment of tubal infertility (4).  
2.5. Advantages of endoscopic management over conventional management 
 cosmetically most acceptable. 
 shorter hospital stay.  
 lower incidence of ileus.  
 faster recovery. 
 less post-operative pain and discomfort, and  
 earlier resumption of normal activities and employment.  
 reduced contamination of the surgical field with glove powder or lint. 
 bleeding is reduced due to tamponade of small vessels by the pneumoperitoneum  
 drying of tissues is minimal because surgery occurs in a closed environment  
 easy intraoperative access to the pouch of Douglas and the posterior aspects of the 
genital organ.  
2.6. Fertility-preserving reconstructive gynecologic surgery 
 Avoidance of serosal insults: tissue trauma, ischemia, hemorrhage, infection, foreign-
body reaction, and leaving raw surfaces.  
  minimizing tissue trauma: by using atruamatic techniques, meticulous hemostasis, 
complete excision of abnormal tissues and precise alignment and approximation of 
tissue planes .  
Evidence of superiority of Laparoscopic reconstructive surgery: one study proved that 
reconstructive surgery achieves a double pregnancy rate than non-reconstructive surgery 
(5).  
2.7. Is there a role for robotic surgery in improving pregnancy rate? 
Among experienced endoscopists, it’s well known that it’s not the robot that does the 
surgery, it’s the surgeon! 
In a retrospective study, both robotically-assisted laparoscopic and standard laparoscopic 
treatments of endometriosis had excellent outcomes. The robotic technique required 
significantly longer surgical and anesthesia time, as well as larger trocars (6). 
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Facts Myth
no demonstration that it 
increasesspeed or safety 
Three-D vision
No RCT The surgeon sees up to 30% more endometriosis.
No RCT Less recurrence and slowly
No RCT Rapid recovery and smooth postop course
this point is debated 
among experts. 
The dexterity (ability to bend at the “wrist”) of the robotic 
instruments makes it possible to perform some surgeries 
laparoscopically that would otherwise require laparotomy.
Table 2. Pros and cons of Robotic surgery 
 
Figure 1. Robotic surgery in Gynecology 
2.8. Can IVF replace endoscopy? 
Due to advances in the field of IVF/ICSI and stratification of management plans worldwide, 
the overall pregnancy rate following IVF/ICSI overcame that following endoscopic surgery 
in many centers. These encouraging results made some authors consider ART superior to 
surgery and should be offered as a first-line treatment (7).  
2.9. Which approach should we use: expectant, endoscopy or ART? (8) 
The treatment choice depends upon: 
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 Severity of the tubal disease. 
 Duration of subfertility. 
 Maternal age. 
 Coexisting infertility factors.  
Despite the widespread utilization of assisted reproductive techniques in recent years, 
hysteroscopic as well as laparoscopic surgery should be firstly offered for patients with 
adnexal and uterine lesions desiring fertility. Permanent correction of the patient’s problem 
with frequent chances of pregnancy is a definite advantage of endoscopic surgery over 
assisted reproductive techniques. Reconstructive endoscopic procedures could be 
performed for fertile women as well e.g. hysteroscopic or laparoscopic myomectomy for 
abnormal bleeding. The concept of reconstruction following microsurgical principles 
coupled with refinement of instrumentation and techniques is would improve the results of 
hysteroscopic and laparoscopic approaches. It is expected to expand to cover many 
gynecologic aspects in the coming years particularly with the continuous advances in 
technology of fine endoscopic surgery and the development of more suitable robotic 
instrumentation.  
2.10. Laparoscopy and IVF/ICSI are complementary since a long time (9) 
The first in vitro fertilization (IVF) child ensued following the partnership by a scientist with 
a focused ambition (Nobel laureate Robert Edwards) joining with the gynecologist who 
introduced laparoscopy to Britain in the late 60's (Patrick Steptoe). Egg retrieval was done 
laparoscopically. In modern practice, laparoscopic egg retrieval is still required whenever 
inaccessible ovaries are encountered. A trial of transabdominal sonographic aspiration was 
recently published with lower success rate of egg retrieval if compared to transvaginal 
sonographic aspiration (10). 
Laparoscopic GIFT: a blastocyst intrafallopian transfer was associated with an intrauterine 
pregnancy; however, when the indication for blastocyst tubal transfer of an obstructed 
cervix is associated with a foreshortened cervix requiring cervical cerclage, there can be 
major health risks for infant and mother (11). 
2.11. What’s the best approach? 
Always try to use the appropriate approach for a suitable couple at the appropriate time. To 
achieve the best results, try to stratify the lines of management according to pathology 
putting in mind other circumstances. The following are examples of how to think in each 
case separately. 
3. Pelvic endometriosis: A good example of how to individualize 
treatment 
The optimal management of endometriotic ovarian cysts in infertile patients is less well 
defined. Recent evidence of reduced responsiveness to gonadotrophins following 
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laparoscopic ovarian cystectomy has challenged the traditional surgical approach to 
treatment (12). Indeed, it has been suggested that surgery should be undertaken only for the 
treatment of large endometriomas or pain that is refractory to medical treatment, or to 
exclude malignancy (13).  
Laparoscopic surgery may be of benefit in treating subfertility associated with mild to 
moderate endometriosis. However, additional studies in this field are needed before 
definitive conclusions can be drawn (14). Laparoscopic excision of ovarian endometriomas 
more than 3 cm in diameter may improve fertility. (level II evidence). The effect on fertility 
of surgical treatment of deeply infiltrating endometriosis is controversial (level II evidence). 
3.1. Is there a need to treat endometriosis in patients undergoing IVF? 
In a meta-analysis (15)the chance of achieving pregnancy after IVF was significantly lower 
for patients with endometriosis (odds ratio, 0.56; 95% confidence interval, 0.44-0.70), as 
compared to those withtubal factor. They also reported decreased fertilization rates, 
implantation rates and in the number of oocytes retrieved. 
3.2. Mild endometriosis Vs severe endometriosis prior to IVF/ICSI 
The same study (15) reported that the probability of pregnancy was reduced in women with 
severe endometriosis as compared to those with mild disease. 
Contrarily, a recent retrospective poorly designed study (16) demonstrated that ovarian 
endometriosis does not reduce IVF outcome compared with tubal factor. Furthermore, 
laparoscopic removal of endometriomas does not improve IVF results, but may cause a 
decrease of ovarian responsiveness to gonadotropins. Nevertheless, they included a bizarre 
group of patients with one or more endometrioma, unilateral or bilateral with a size of6 cm 
and more importantly symptomatic as well as asymptomatic cases. In addition to being a 
retrospective analysis, these heterogenous criteria would weaken this study. We believe that 
stripping off cyst wall of a unilateral endometrioma wouldn’t be expected to affect ovarian 
reserve or ovarian response to gonadotropins.  
3.3. Advantages of laparoscopic surgery for endometriosis prior to IVF (ESHRE 
Recommendations, 2005) (17) 
 confirms the diagnosis histologically  
 reduces the risk of infection  
 improvesaccess to follicles 
  Improves ovarian response.  
3.4. More advantages include 
 Spontaneous pregnancy in mild and moderate disease. 
 Elimination of pelvic pain by destruction of the peritneal endometriotic lesions which 
may be mistaken by OHSS if the patient is subjected to IUI.  
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3.5. Precautions of laparoscopic surgery prior to IVF/ICSI 
- The woman should be counseled regarding the risks of reduced ovarian function after 
surgery and the loss of the ovary.  
- The decision should be reconsidered if she has had previous ovarian surgery.  
- RCTs showed that the excision technique is associated with a higher pregnancy rate and a 
lower rate of recurrence although it may determine severe injury to the ovarian reserve.  
- Improvements to this latter aspect may be represented by a combined excision-
vaporization technique or by replacing diathermy coagulation with surgical ovarian 
suture.  
4. Role of hysteroscopy prior to assisted reproduction 
Failure of IVF treatment can be broadly attributed to embryonic, uterine or transfer factors, 
but remains unexplained in most cases (18). A number of interventions have been proposed 
to improve IVF outcome, many of which are not strictly evidence-based and their efficacy in 
improving pregnancy rates remains controversial (19,20). One of the main causes of failure 
of implantation after proper embryo transfer is intrauterine pathology. Whether to perform 
hysteroscopic evaluation of the endometrial cavity prior to IVF/ICSI especially in patients 
with repeated failures is a controversial issue that is open for criticism and deserves further 
studies (21). 
In a systematic review (Level Ia evidence), 5 reliable studies were included (22). Two RCT 
showed a statistically significant improvement in the clinical pregnancy rate in the group 
who had office hysteroscopy (pooled RR = 1.57, 95% CI 1.29–1.92, P < 0.00001). The 
miscarriage rate was not statistically different between the office hysteoscopy and control 
groups in either study (24% versus 29%, respectively, RR = 0.83, 95% CI 0.56–1.21, P = 0.33). 
Three non-randomized controlled studies suggests that office hysteroscopy improves the 
pregnancy rate in the subsequent IVF cycle (pooled RR = 2.01, 95% CI 1.60–2.52, P < 0.00001). 
In addition to the well known diagnostic as well as therapeutic advantages of performing 
hysteroscopy, even if the endometrial cavity was completely free, high pregnancy rate was 
achieved after diagnostic hysteroscopy since uterine instrumentation during hysteroscopy 
would inevitably cause a degree of endometrial injury and provokes a posttraumatic 
reaction that involves release of cytokines and growth factors (23,24), which in turn may 
influence the likelihood of implantation (25). Commencing IVF treatment soon after 
hysteroscopy may take advantage of this immunological response (26). Performing 
diagnostic hysteroscopy before assisted reproductive technologies (ART) may be advisable 
not only from the clinical but also from the economic point of view (27). Enhanced clinical 
pregnancy rates would be achieved on adding office hysteroscopy as a complementary step 
prior to IVFspecially patients with recurrent IVF embryo transfer failures even after normal 
hysterosalpingography findings. Some abnormal intrauterine findings that would affect the 
prognosis of IVF/ICSI can be easily diagnosed by hysteroscopy like chronic endometritis, 
Müllerian anomalies, retained fetal bones, or endocervical ossification. Moreover, contact 
hysteroscopy may reveal addition valuable findings such as polyposis, strawberry pattern, 
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hypervascularisation, irregular endometrium with endometrial defects, or cystic 
haemorrhagic lesion which are commonly seen with adenomyosis (28). Future high-quality 
randomized trials are needed to confirm the favorable effect of standard hysteroscopy in 
different IVF populations and examine whether newer and less invasive techniques of 
uterine cavity evaluation such as mini-hysteroscopy (29) or hysterocontrast sonography (30) 
would have an equally beneficial effect when compared with no intervention before IVF.  
With the advent of technical refinements and advancement in hysteroscopic surgery, it is 
expected that preoperative hysteroscopic evaluation of uteri prior to IVF/ICSI would be 
widely performed. Unfortunately, many of studies on this topic focus on the central role of 
hysteroscopic examination of the endometrial cavity in cases with recurrent failures 
(28,31,32). This concept should be reviewed since office hysteroscopy or minihysteroscopy is 
a simple outpatient conscious procedure (33-34) that provides excellent information on the 
implantation site in the endometrial cavity in a very short time. Relying on 
hysterosalpingography alone may be fallacious in some cases of fine intrauterine adhesions 
that may be masked by dye especially oily dye. Likewise, transvaginal ultrasonography as 
well as sonohysterograohy may miss some important fine intrautrerine lesions thatwould 
simply contribute for failures (3). In one study, hysteroscopy succeeded to diagnose and 
treat intrauterine lesions in 26% of patients prior to starting trials of assisted reproduction 
(31). In a big sample sized study (36), intrauterine pathology was diagnosed in about 23% of 
2500 cases prior to IVF trial. Another study diagnosed abnormalities in only 11 out of 678 
cases. On reevaluation of DVD records of hysteroscopy by an experienced team, the same 
team reported perfect diagnosis in 77.6% of cases (37). 
Following recurrent IVF failure there is some evidence of benefit from hysteroscopy in 
increasing the chance of pregnancy in the subsequent IVF cycle, both in those with abnormal 
and normal hysteroscopic findings. Various possible mechanisms have been proposed for 
this beneficial effect, but more randomized controlled trials are needed before its routine use 
in the general subfertile population can be recommended (38).  
4.1. What is the ideal approach prior to IVF? 
In recent years, conflicting opinions on the role of hysteroscopy before any case of IVF/ICSI 
or after failure once or more times. This conflict is due to different circumstances in different 
parts of the world regarding:availability of free health insurance for IVF, experienced 
hysteroscopists, availability of high-resolution 2D ultrasonography with or without SIS, use 
of office versus conventional hysteroscopes, use of vaginoscopic approach or not and 
socioeconomic level of the couple. Our opinion is summarized as follows:  
 In centers where health insurance is covering the cycles, experienced sonographers 
performing high-resolution 2D ultrasonography with or without SIS, we believe that 
they can proceed for IVF without prior hysteroscopy. 
 In centers where health insurance is not covering the cycles, experienced sonographers 
performing high-resolution 2D ultrasonography with or without SIS are not available, 
we believe that hysteroscopy specially office is very useful in such cases. 
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 In cases of failed IVF once, hysteroscopy is valuable and recommended. 
 In cases with recurrent implantation failure, hysteroscopy is mandatory. 
4.2. Office hysteroscopy versus saline-infusion sonography (SIS) 
In 1999, we published our first series of SIS for screening in infertile patients utilizing 0.9% 
saline as an infusion solution and Nelaton catheters for injection (39). We reported satisfactory 
results. One year later, we published a study (40) on the efficacy of SIS for the detection of 
endometrial polyps in comparison to the conventional hysteroscopy. These studies compared 
SIS versus conventional hysteroscopy with excellent results in favor of SIS. Later on, we 
introduced office hysteroscopy (I use it since 2002 utilizing 2.6 mm telescope). With the advent 
of vaginoscopic approach, the procedure gained more acceptability among our patients. Now, 
after these years of experience we changed our mind and strongly say that office hysteroscopy 
can easily replace indirect diagnostic tools like SIS or 4D ultrasonography. Moreover, more 
detailed description of the endometrial cavity particularly the blood vessels would be obtained 
only with office hysteroscopy as we recently published (41). 
5. Role of hysteroscopy after embryo transfer 
In a study evaluating the incidence of endometrial injury following embryo transfer, office 
hysteroscopy was performed immediately following embryo transfer and demonstrated 
marked endocervical and endometrial damage following rigid catheters more than soft 
catheters (42). Even for cases of early abortion following IVF/ICSI, hysteroscopy was proved to 
be very valuable. In one study (43), among 84 early abortion patients after IVF-ET, it succeeded 
to diagnose intrauterine abnormalities in 58 (69.05%) of the patients, including intrauterine 
adhesion in 32 (32/84, 38.10%), endometrial polyps in 12 (12/84, 14.29%), endometritis in 10 
(10/84, 11.90%), submucous leiomyoma in 3 (3/84, 3.57%) and septa in 1 (1/84, 1.19%).  
6. Hysteroscopic embryo transfer 
As a trial of improving implantation rate following IVF/ICSI, some scattered papers 
described hysteroscopically-guided embryo transfer. Principally, hysteroscopic approach 
was selected in difficult cases of embryo transfer (44).  
6.1. A new hysteroscopic tubal embryo transfer catheter was developed  
Catheterization was performed in 60 patients at hysteroscopic insemination into tube, using 
3 French catheters, in which the distal 3,4, and 5 cm tapered to 2 French. Hysteroscopic tubal 
embryo transfer and conventional IVE-ET were performed in 30 patients with normal tubes, 
who failed to achieve pregnancy after 2 IVF-ET trials. The success rate of complete insertion 
with the catheter tapering at the distal 3 cm was significantly higher than that at the distal 5 
cm. Since we obtained the highest success rate of insertion with the catheter tapering at the 
distal 3 cm, we selected this catheter for the h-TEST. The rate of pregnancy in h-TEST was 
significantly higher than that in conventional ET (45). 
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6.2. Hysteroscopic Endometrial Embryo Delivery (HEED) (46) 
It refers to visually confirmed placement of the embryo(s) at a specific area on the surface of 
the uterus. It is done in an office setting, using a special fiberoptic scope and camera plus 
special tubing, and it takes approximately two minutes to perform. It uses nitrogen gas to 
avoid deleterious effect of CO2 gas o n the embryos. HEED can also be used for earlier (day 
2 or 3) embryos as well as the more advanced embryos. This is especially advantageous in 
situations where the numbers of embryos are limited, or embryo quality is of concern. It is 
particularly useful in patients with advanced reproductive age, or when egg production is 
low, or in patients with poor sperm parameters. Patients will actually see the process on 
video monitor. The entry into the uterus is not always easy, as the non-stirrable tip of the 
catheter must usually go through different curvatures in the cervical canal and the uterine 
cavity while minimizing injury to the lining of the uterus, before it reaches the final 
destination. The flexible hysteroscope has a stirrable tip, helping guide the endoscope in a 
gas expanded uterine cavity. The slightly expanded uterine cavity also helps avoid contact 
between the hysteroscope and uterine surface. The final destination of the tip of the catheter 
is visually confirmed. This more precise placement and lower volume of transfer fluid may 
help reduce incidence of ectopic pregnancies even further. It may also reduce chances 
placenta previa, where the after birth is lying over the uterine opening. Presence of uterine 
contraction at the time of transfer that are otherwise not noticeable by using the “Blind” 
embryo transfer technique, can be visually confirmed and embryo transfer deferred. Precise 
and visually confirmed placement, may reduce percentage of multiple pregnancies, by 
reducing number of embryos transferred because of the less uncertainty of the placement of 
embryos with the “Blind” technique. Nevertheless, since the embryo(s) are laid on top of the 
uterine surface, due to inherent uterine contractions over the next few days after the embryo 
delivery and prior to their natural implantation in the uterine cavity, the embryo(s) may be 
expelled either into the fallopian tube (causing ectopic pregnancy) or out of the uterus, as 
they do with the current “blind” embryo transfer technique.  
6.3. Subendometrial embryo delivery (SEED) (47)  
Patients will actually see the process on video monitor. It will reduce the chances that the 
embryo will fall out of the uterus, or that it will fall into the fallopian tube causing tubal 
pregnancy. Post embryo implantation, the woman does NOT need to stay in bed for 2 days. 
The main disadvantage includes a possible scratching of the lining of the uterus so that 
pregnancy may not ensue. Candidates include any patient undergoing IVF, specially 
patients with previously failed standard embryo transfers, patients with ectopic pregnancies 
and tubal disease. 
It is done in an office setting using a special fiberoptic scope and camera plus a special 
tubing with a needlepoint, and it takes approximately two minutes to perform. It utilizes 
flexible hysteroscope and an inert gas (nitrous gas) to avoid the deleterious effect of CO2 gas 
on the embryos. 
 
Endoscopy versus IVF: The Way to Go 
 
37 
6.4. Hysteroscopic cervical canal refashioning prior to difficult embryo transfer 
(48) 
In some cases, access to the endometrial cavity is extremely difficult or even impossible. In 
some scarce studies. Sonographically-guided fine needle transmyometrial embryo transfer 
was tried but this technique is not universally accepted. An attractive recent hysteroscopic 
approach was described. The procedure is performed under general anesthesia. Patients are 
taken into the theater with a full bladder in case ultrasound guidance is required to access 
the uterine cavity. A Versapoint electrode (twizzle electrode) with a 1.9 mm Versascope 
(Gynecare division, Johnson and Johnson) is used for the procedure. The Versapoint 
electrode works on bipolar energy, so saline is used as the distension media. Versascope 
sheath has a small diameter (3.5 mm) and it can be inserted into the cervical canal without 
prior dilatation or with minimal dilatation. In two patients the canal is extremely tortuous 
and fibrotic and it is not possible to negotiate with the delicate Versascope. Cervical 
dilatation is achieved under ultrasound guidance in these women and the Versapoint 
twizzle electrode is introduced through the operating channel of an operating hysteroscope 
(Olympus). 
 
Figure 2. Hysteroscopic cervical canal refashoning 
For women with a false passage and acute angulation of the uterus, the tissue between the 
actual cervical canal and false passage is cut thus leaving a clean path which could be 
negotiated with an ET catheter. For the problem of a severely fibrotic OS, 1 or 2 linear 
releasing incisions are made with the Versapoint electrode, extending from the posterior 
aspect of the internal OS towards the external OS for approximately 1 cm. In patients who 
had a tortuous cervical canal, several projecting ridges are seen arising from the anterior, 
posterior and/or lateral walls of the cervical canal. The hysteroscope is introduced into the 
uterine cavity and then withdrawn towards the external OS. As the hysteroscope is moved 
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outwards the cervical canal projections distorting linearity of the canal are visualized. Linear 
releasing incisions of approximately a centimeter are made into these projections and a 
straightening of the canal is achieved. Subsequent to the procedure, dilatation is done to 
further stretch the incised fibrous tissue, and it is now possible to dilate the cervix up to size 
10/12 Hegar in even the most resistant cervix. 
6.5. Hysteroscopic site-specific endometrial injury (49) 
A site-specific hysteroscopic biopsy-induced injury of the endometrium during the 
controlled ovarian hyperstimulation cycle has been shown to improve subsequent embryo 
implantation in patients with repeated implantation failure. The procedure starts with 
performing panoramic hysteroscopy. A flexible claw forceps is introduced through a 2.2 mm 
working channel which is used to generate a local injury on the posterior endometrium at 
midline 10-15 mm from the fundus on D4 to D7 of the stimulation cycle. The depth and 
width of the injured site is 2 × 2 mm (i.e. a bite of the claw forceps). No antibiotic or 
hemostatic drug is administered after the procedure. 
Endometrial injury may have a beneficial role in implantation and improve the pregnancy 
rate. However, there are still many unanswered question including patients selection, 
timing, technique and number of endometrial biopsies needed (50).  
7. Role of endoscopy in cases of hydrosalpnix 
 Tubal pathology, particularly hydrosalpinx, is associated with a low embryo 
implantation rate in IVF as well as an increased risk for early pregnancy loss.  
 The role of surgery for tubal disease to improve IVF outcomes, in the absence of 
hydrosalpinx, requires further evaluation.  
In recent years, considerable attention has been given to the possible impact of the presence 
of hydrosalpinx on implantation and ongoing pregnancy rates following IVF/ICSI (51,52). 
The mechanism of disruption remains uncertain. However, proposed mechanisms may be 
attributed to alteration in endometrial receptivity ordirect embryo toxic effect (53). 
Furthermore, hydrosalpnix is liable be unintentionally punctured at the time of egg retrieval 
or it may disturb the access to the ovary if it is too big. A systematic review of three RCTs 
(54) showed that tubal surgery such as laparoscopic salpingectomy significantly increased 
live birth rate (OR 2.13; 95% CI 1.24 to 3.65) and pregnancy rate (OR 1.75; 95% CI 1.07 to 
2.86) in women with hydrosalpinges before IVF when compared with no treatment. There 
are no significant differences in the odds of ectopicpregnancy (OR 0.42; 95% CI 0.08 to 2.14), 
miscarriage (OR 0.49; 95% CI 0.16 to 1.52), treatment complication (OR 5.80; 95% CI 0.35 to 
96.79) or implantation (OR 1.34; 95% CI 0.87to 2.05). Since hydrosalpinx reduces IVF 
pregnancy rates (14,55), it is therefore suggested that women with hydrosalpinges should be 
offered diagnostic/operative laparoscopy and a trial of salpingoneostomy. If failed or 
inaccessable, salpingectomy could be offered prior to IVF/ICSI to improve the chance of a 
live birth. Sometimes, laparoscopic access to the isthmic part of the tube is not feasible even 
in experienced hands particularly in patients with history of repeated laparotomies, 
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intestinal reanastomosis, or kidney transplantation. This situation may pave the way to 
hysteroscopic occlusion of the fallopian tubes based on the reported success in hysteroscopic 
tubal cannulation and sterilization techniques. The effectiveness of draining of 
hydrosalpinges or performing salpingostomy on improving live birth rate prior to IVF/ICSI 
needs further evaluation.  
7.1. Methods of endoscopic proximal occlusion of functionless and harmful 
hysrosalpnix 
1. Laparoscopic: this can be easily performed using a bipolar grasping forceps or 
monopolar grasping forceps. In either approach, take care to apply a little traction on 
the tube medially to avoid scattered secondary coagulation towards the lateral pelvic 
wall particularly when utilizing monopolar diathermy. By this way, the ureter would 
be perfectly secured. Some center using clips. 
2. Hysteroscopic: this approach can be performed whenever laparoscopic approach is 
impossible or dangerous like cases with history of extensive abdominal surgery like 
resection anastomosis of the intestine or previous colonic surgery, or patients with a 
history of extensive or recurrent surgery for pelvic endometriosis. Practically, 
endoscopists may face some cases without feasibility to perform laparoscopy from the 
start. These cases deserve searching for an alternative approaches. Hysteroscopy comes 
as an attractive valuable alternative. Some studies used Essure devices to 
hysteroscopically occlude the proximal part of the fallopian tube. They reported some 
case reports of successful pregnancy. Nevertheless, we believe that leaving a foreign 
body in-utero would lead to decreasing implantation rate. Herein, I’ll discuss in details 
our previous unique study on hysteroscopic tubal occlusion in cases with hydrosalpnix 
(56). The in-vitro safety phase of this study is done on fresh uterine specimens removed 
by abdominal or vaginal hysterectomy. In this phase the study, fresh hysterectomy 
specimens are placed on the return electrode of diathermy, then the corneal ends of 
both tubes are coagulated simulating the same manner as in the clinical phase. 
Temperature study is done using digital thermometer over the uterine serosa at site of 
the coagulation. Histopathologic sections are made to assess tissue effects and depth of 
penetration using Nitro Blue Tetrazolium (NBT) to evaluate the extent of coagulation 
on the tubal uterine junction. Computerized image analyzer (Leica Q 500 MB 
Computerized Image Analyzer) is used to measure the depth of diathermy damage to 
the surrounding myometrium. The clinical phase of this study is conducted at the out-
patient Infertility clinic of Women Health hospital, Assiut University, from April 2004 
to October 2006 and included 27 patients with definite uni- or bilateral laparoscopically-
proved functionless hydrosalpinges scheduled for IVF/ICSI. All patients gave a written 
consent and the study is approved by the institutional ethics committee. They were 
randomly divided into 2 groups. Randomization is done using simple computer 
generated randomization tables method. Group A comprised 14 patients who were 
randomly allocated for laparoscopic occlusion. Laparoscopy is performed under 
general endotracheal anesthesia using a standard double puncture technique. Once the 
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peritoneal cavity is entered, a panoramic evaluation of the pelvis is done. If the pelvis 
looks frozen or if the access to the fallopian tubes is impossible, the patient is 
considered failed laparoscopic approach. Those cases are subsequently treated by open 
laparotomic or hysteroscopic approach but the results of these procedures are not 
included in this study. If the procedure seems feasible, a third auxillary puncture is 
done. Utilizing a bipolar forceps, the isthmic part of the fallopian tube is coagulated and 
incised to ensure complete tubal occlusion as a case of tubal sterilization. The procedure 
is completed after securing hemostasis. The patient is discharged after 3-4 hours under 
antibiotic prophylaxis. Group B included 13 patients scheduled for hysteroscopic 
approach. The cervix is primed in all cases using 200 Mg misoprostol 8 hours prior to 
the procedure as previously described (57). The procedure is done immediately 
postmenstrual without specific preparation. Local paracervical anesthesia is selected in 
5 cases while spinal anesthesia in 6 cases, and general anesthesia in 2 cases. Selection of 
the anesthestic technique is chosen according to patient preference after proper 
explanation by the anesthiologist. The cervix is gently dilated till Hegar's 10 which is 
followed by insertion of a rotatory continuous flow monopolar resectoscope. Once the 
peritubal pulge (the proximal part of the intramural segment of the tubeis clearly seen, 
a roller ball electrode of 3 mm size is bluged inside it and activated at 50 watts for about 
8 seconds. A thorough comment on the fundus and the rest of the endometrial cavity is 
reported. The patients are discharged immediately if the procedure is done under local 
paracervical anesthesia, while the remaining cases are discharged few hours later. In 
both groups, the procedure is preceded and done under prophylactic broad spectrum 
antibiotic coverage to guard against any risk of flaring up of infection of the 
functionless hydrosalpnix. In both groups, patients are instructed to come back the next 
cycle postmenstually where hysterosalpingography (HSG) is done for most cases 
especially those with unilateral functionless hydrosalpnix. If the patient refused and has 
bilateral hydrosalpnix, sonohysterography (SHG) is done utilizing a simplified 
technique as previously described (39). Tubal occlusion of the affected side is confirmed 
if marked resistance is encountered on repeated injection of saline without evidence of 
intraperitoneal leakage from the occluded side which is the main outcome measure. 
Second-look office hysteroscopy is done for patients in group B whenever possible. The 
in-vitro safety phase resulted in bilateral complete coagulation of the proximal part of 
the tubes with secondary coagulation shown of up to 3 mm as shown in the 
histopathologic sections. When the power of coagulation is 50-60 W and operating time 
not prolonged more than 20 seconds , the thermal damage covered corneal end as 
complete coagulation in addition to2mm -3 mm secondary coagulation of the adjacent 
cornualendo- myometrium. Serosal temperature is not exceeding 41.9 Cº (range 39 Cº - 
41.9 Cº) at any time during the procedure. No full thickness injuries are demonstrated 
either histologically or suggested by the temperature studies. Hysteroscopic access is 
achieved in 12 (85.7%)and occlusion is achieved in 9 (64.2%) cases. If the peritubal pulge 
is not clearly visible, the case is considered as failed access to the proper site of 
occlusion. In group B, diagnostic hysteroscopy showed fine marginal adhesions in 2 
cases (15%) and a small polyp in one case (7.7%). Hysteroscopic tubal occlusion showed 
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shorter operative time (9 ±2.76 min vs. 23.6 ±4.75 min, p= 0.0001) and hospital stay as 
well (2 ±1.84 hours vs. 5 ±1.13 hours, p= 0.0001). No case of intraoperative complication 
in either group is reported. There is no case of exaggerated postoperative pelvic pain or 
fever in either group. HSG or SHG demonstrated complete tubal occlusion of the 
affected side in all cases in both groups). Second-look office hysteroscopy is done in 8 
cases of group B which revealed no significant corneal lesions at the site of 
hysteroscopic occlusion. Pregnancy is achieved in 4 (28.5%) and 4(30.7%) cases in both 
groups respectively following IVF/ICSI without any significant difference between both 
groups.  
7.2. Comments on hysteroscopic tubal occlusion in hydrosalpnix 
Hysteroscopic tubal occlusion of functionless hydrosdalpngies is a unioque one. It 
demonstrates a valuable role of hysteroscopic approach that can be performed in difficult 
cases with poor access to the isthmic part of the tubes via laparoscopy even with 
experienced hands. The idea is attractive but further large-sample sized studies are required 
to define the exact role of this approach. 
One of the interesting additive items of this paper to the literature is the term "functionless" 
hydrosalpnix. The proposed definition is very crucial to stratify cases suitable for 
microsurgical salpingoneotomy and those cases suitable for occlusive procedures. By this 
way, the place of reconstructive surgery is still preserved in modern practice even in the era 
of IVF/ICSI. Ethically, every effort should be exerted to restore normal anatomy whenever 
possible. This concept is of utmost importance particularly for the developing countries with 
limited resources where no national programs to support assisted reproductive techniques. 
Microsurgery to correct localized damage has the advantage of long-standing restoration of 
fertility. A simple prognostic classification is lacking. The severity of the tubal damage and 
the health of the mucosa is key in determining outcome. Proper selection of the tube for 
either line of management requires expert knowledge with the principles of salpingoscopy. 
Salpingoscopy during laparoscopy yields the best prognosis in patients with hydrosalpinx. 
Performing salpingoscopy with laparoscopy could significantly increase accuracy in 
predicting short-term fertility outcome. Whenever the mucosa is unhealthy, surgery is not 
justified; early referral for IVF is indicated. 
Hysteroscopic tubal occlusion of proximal part of the hydrosalpnix is feasible and 
promising as a safe, effective, fast, and easy approach. It can be done as an out-patient 
procedure under local paracervical block. It has the advantage of adding valuable 
evaluation of the endometrial cavity prior to IVF/ICSI. Further large sample-sized studies 
are required specially those utilizing bipolar resectoscope. The impact of hysteroscopic 
tubal occlusion on subsequent implantation and pregnancy rates needs to be addressed in 
another larger study. Since it is a preliminary study, the current role of hysteroscopic 
occlusion should be limited to cases of failed laparoscopic approach. Further studies are 
required before moving hysteroscopic occlusion to replace laparoscopic occlusion prior to 
IVF/ICSI. 
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7.3. A suggested flowchart for management of functionless hydrosalpnix prior to 
IVF/ICSI 
Laparoscopic tubal surgery: tubal factors include proximal tubal occlusion, distal tubal 
phimosis or occlusion or peritubal adhesions. Endoscopy (whether laparoscopy or 
hysteroscopy) play a central role in the management of tubal disease. 
 Tubal pathology, particularly hydrosalpinx, is associated with a low embryo 
implantation rate in IVF as well as an increased risk for early pregnancy loss.  
 The role of surgery for tubal disease to improve IVF outcomes, in the absence of 
hydrosalpinx, requires further evaluation. 
 
Figure 3. HSG: Hysterosalpingography. TVS: Transvaginal ultrasonography. 
7.4. Laparoscopic management of distal tubal disease 
Distal tubal occlusion may be due to hydrosalpnix, pyosalpnix or peritubal adhesions. 
Obstruction of the distal fallopian tube is one of the most common causes of female infertility 
(58). In cases of pyosalpnix, just tubal opening, drainage of pus and proper peritoneal toilet are 
sufficient. Don't forget to take a tubal wall biopsy. Don't proceed for tubal occlusion at the 
same setting for fear of disseminating infection and the possibility of tubal bilharziasis with 
reported cases of spontaneous pregnancy after proper treatment. Nowadays, it is conceived 
that the presence of hydrosalpinx is associated with a compromised outcome for IVF/ ICSI. 
Hydrosalpinx is associated with lower implantation and fecundibility rates even if the 
contralateral tube is sound which may be attributed to alteration in endometrial receptivity 
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(59) or direct embryo toxic effect. Furthermore, it is liable to be unintentionally punctured at 
the time of egg retrieval or it may disturb access to the ovary if it is too big. In a meta-analysis, 
it has been demonstrated that there is a reduction by half in the probability of achieving a 
pregnancy in the presence of hydrosalpinx, and an almost doubled rate of spontaneous 
abortion (60). In an animal study, hydrosalpinx fluid is shown to contain toxins that are 
potentially teratogenic (61). Proposed mechanisms of impaired implantation rate due to 
hydrosalpinges are well addressed in the literature (62). Selected patients with unilateral 
hydrosalpinges and a patent contralateral Fallopian tube may exhibit increased cycle fecundity 
after salpingectomy or proximal tubal occlusion of the affected tube, and may conceive 
without the need for IVF. In a retrospective case-control study, bilateral salpingectomy due to 
hydrosalpinges restored a normal delivery as well as implantation rate after IVF treatment 
compared to controls (63). Randomized controlled trials recommended performing 
laparoscopic salpingectomy prior to IVF, especially inpatients with ultrasound-visible 
hydrosalpinges (64). In a Cochrane review (65), it is concluded that further randomized trials 
are required to assess other surgical treatments for hydrosalpinx, such as salpingostomy, tubal 
occlusion or needle drainage of a hydrosalpinx at oocyte retrieval. Functionless hydrosalpinx 
can be defined as a large blocked tube with lost major and minor folds, as seen at 
salpingoscopy after laparoscopic salpingoneostomy.  
 
Figure 4. Sonographic appearance of a typical hydrosalpnix. 
On sonography, the dilated fallopian tube presents as a thin- or thick-walled tubular fluid-
filled structure that may be elongated or folded (figure). Longitudinal folds that are present 
in a normal fallopian tube may become thickened in the presence of a hydrosalpinx. The 
dilated fallopian tube may or may not show longitudinal folds. These longitudinal folds are 
pathognomonic of a hydrosalpinx . If the elongated nature of these folds is not noted, they 
may be mistaken for mural nodules of an ovarian cystic mass. Identification of a separate 
ovary helps distinguish a hydrosalpinx from a cystic ovarian mass, an important distinction 
because malignancy is rare with an extraovarian cystic adnexal mass. A significantly scarred 
hydrosalpinx may present as a multilocular cystic mass with multiple septa creating 
multiple compartments. These septa are generally incomplete, and the compartments can be 
connected. However, with more pronounced scarring, differentiation from an ovarian mass 
may not be possible (66). Potential pitfalls in the diagnosis of hydrosalpinx include 
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paratubal, paraovarian, or perineural cysts. In some cases, CT or MRI may be helpful to 
differentiate these conditions from a hydrosalpinx (67).  
7.5. Technical tricks of laparoscopic management of hydrosalpnix 
a. Salpingoneostomy: One of the keys of success is to evaluate the tube externally and 
internally. If peritubal adhesions exist, microsurgical adhesiolysis should be performed 
at first. Be sure that the tube is freely mobile. Imagine the site of the new ostium before 
dealing with the hydroslpnix. It should be directed towards the pouch of Douglas to 
help ovum pick-up. Start by salpingoneostomy using a fine monopolar or bipolar 
needle. The finest the needle, the better ostium. Incise the distended distal part of the 
tube “ + shaped” (cruciate incision). Then, evaluate the tubal mucosa using a 
salpingoscopy. Practically, use the diagnostic hysteroscopy which consists of a 4 mm 
telescope and a 5 mm outer sheath. Connect it to a normal IV infusion set and use saline 
as an irrigating fluid. Grasp the new ostium with an atruamatic grasping forceps and 
insert the hysteroscope with comment on the major and minor folds till reaching the 
narrowest part of the tube. If major and minor folds are lost this means that the 
prognosis is poor even after proper refashioning. The next step is to grasp the tubal 
lumen with atruamatic forcpes and to evert it outside. Lastly, fix the edges of the new 
ostium either with monopolar spray coagulation just distal to the incised parts to evert 
them or with the aid of fine sutures. 
b. Salpingectomy: This procedure is indicated if a pathologic unilateral huge hydrosalpnix 
is present to enhance spontaneous pregnancy or bilateral big hydrosalpnix before 
IVF/ICSI. It is performed in the same manner as mentioned in the section of EP. 
c. Tubal occlusion: Once the peritoneal cavity is entered, a panoramic evaluation of the 
pelvis is performed. If the pelvis looked frozen or if access to the fallopian tubes is 
impossible, the patient is considered a failed laparoscopic approach. Those cases are 
subsequently treated by open laparotomic or hysteroscopic approach. If the procedure 
seems feasible, a third auxiliary puncture is carried out. Utilizing a bipolar forceps, the 
isthmic part of the fallopian tube is coagulated and incised to ensure complete tubal 
occlusion, as a case of tubal sterilization. The procedure is completed after securing 
hemostasis. The patient is discharged after 3-4 h under antibiotic prophylaxis. 
Laparoscopic salpingectomy or bipolar proximal tubal occlusion yielded statistically 
similar responses to controlled ovarian hyperstimulation and IVF-ET cycle outcome. 
Proximal occlusion might be preferable in patients who present with dense pelvic 
adhesions and easy access only to the proximal fallopian tube (68). Occlusion is 
considered a minimally invasive procedure, requires less experience, feasible in most 
cases, and has fewer burdens on the psychological status of those infertile women. 
Hysteroscopic approach is recently described by our team at Assiut University 
Institution (69). The cervix is primed in all cases using misoprostol (200 µg) 8 h prior to 
the procedure. The procedure is carried out immediately postmenstrual without 
specific preparation. Local paracervical, spinal or general anesthesia could be used. 
Selection of the anaesthetic technique is chosen according to patient preference after 
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proper explanation by the anaesthesiologist. The cervix is gently dilated with Hegar 10 
and a rotatory continuous flow monopolar resectoscope is inserted. Once the peritubal 
bulge (the proximal part of the intramural segment of the tubeis clearly seen, a roller 
ball electrode (size: 3 mm) is introduced inside it and activated at 50 Watts for about 8 
seconds. A thorough comment on the fundus and the rest of the endometrial cavity 
should be reported. The patients are usually discharged immediately if the procedure is 
carried out under local paracervical anesthesia, while the remaining cases are 
discharged a few hours later. 
8. Proximal tubal occlusion 
Usually diagnosed by HSG and confirmed by laparoscopic chromopertubation test. The 
most important job of the endoscopist is to find out contraindications for hysteroscopic tubal 
cannulation procedure which include: 
 florid infection 
 genital tuberculosis 
 obliterative fibrosis and long tubal obliterations that are difficult to bypass with the 
catheter. 
 severe tubal damage. 
 previously performed tubal surgery. 
  salpingitis isthmica nodosa. 
 isthmic occlusion with club-changed terminal, ampullar or fimbrial occlusion, and tubal 
fibrosis 
 coaxial TO: combined distal and proximal tubal occlusion. 
Don't try to cannulate the tube in such cases as failure would be expected and you would be 
disappointed. In cases with isolated tubal occlusion, cannulation would be successful. 
9. The following is our protocol for tubal disease management 
 Pathologic PTO: IVF 
 Isolated PTO: TC 
 Midsegment O: IVF 
 Small hydrosalpnix+ normal salpingoscope:OL 
 Functionless hydrosalpnix: PTO then IVF 
 Combined PTO and DTO: IVF 
 Peritubal adhesions: OL Vs IVF  
10. Endoscopic uterine surgery 
10.1. Endoscopic myomectomy prior to IVF/ICSI 
The impact of uterine myoma on the outcome of IVF/ICSI is a very controversial topic. 
Many centers are overdoing myomectomy for nearly all myomata regardless size and site 
considerations. Contrary, other investigators have shown that fibroids don't exert a 
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deleterious effect. Nevertheless, many studies have provided evidence that uterine myomas 
have a significant effect on IVF outcomes and there is a large body of evidence that 
treatment of uterine myomas increases fertility and pregnancy rates, and decreases the rate 
of pregnancy loss (70). There is no doubt that any cavity-distorting myoma should be 
removed whether completely submucous or interstitial myoma with submucous 
encroachment. This highlights the central role of prior hysteroscopy as well as saline 
infusion solonhysterography (SIS) as previously described (39). Not only does sub mucous 
myoma cause mechanicl interference with implantation, but it also alters endometrial 
receptivity (71)  
Controversy exists for interstitial and subserous myomata. The evidence supports treatment 
of all very large myomas (>7 cm) (70). Subserosal myomas that are smaller than 7 cm in size 
and intramural myomas of less than 4–5 cm in diameter appear to have little effect on IVF 
outcomes. Larger intramural and subserosal myomas present a clinical dilemma and more 
studies are needed to clarify a definitive plan for management (70). In a prospective 
controlled study, the distance between the intramural myomas and the endometrial lining 
did not appear to affect the IVF outcome. An insignificant tendency towards improvement 
of IVF outcome is found in myomas at more than 5 mm from endometrial lining (72).  
In a recent review of literature (73) on myoma and assisted reproduction technology and 
spontaneous conception, hysteroscopic sub-mucous myoma resection is found to increase 
pregnancy rates. Intramural fibroids appear to decrease fertility, but the myomectomy does 
not improve assisted reproduction technology and spontaneous fertility. More high-quality 
studies are needed to conclude toward the value of myomectomy for intramural fibroids. 
Subserosal fibroids do not affect fertility outcomes, and removal does not confer benefit. 
11. Keynote points 
11.1. Tubal infertility 
Endoscopy and ART arenot competitors but complementary. 
First trial is the best trial for tubal surgery.  
Performing laparoscopic surgery Forendometriosis prior to IVF isveryvaluable in 
manycases.  
There is NO adequate trialscomparing pregnancy rates with tubal surgeryversus IVF.  
Per cycle pregnancy rate of IVF: higher  
Tubal anastomosis for reversal ofsterilization has significantly higher cummulative 
pregnancy rate than IVF and ismore cost effective even above 40 years.  
Factors affecting counseling for tubal surgery or IVF:  
- Age of the woman. 
- Ovarian reserve. 
- Number and quality of sperms/ejaculate. 
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- Number of children desired. 
- Site and extent of tubal disease. 
- The presence of other infertility factors. 
- The risk of ectopic pregnancy. 
- The experience of the surgeon. 
- The success rate of IVF program. 
- The patient preference. 
11.2. Uterine myoma and infertility 
Uterine myoma may affect fertility according to its size, site and associated pathology. 
Endoscopic approach has a definite role in its management. HM is the gold standard line of 
management of submucous myoma of suitable size. LM doesn't seem to be superior to 
conventional open myomectomy regarding fertility and is characterized by both short and 
long term drawbacks. Uterine myomata would affect IVF/ICSI outcome whenever 
disturbing the endometrial cavity or large sized. The impact of other types of myomata on 
IVF/ICSI deserves further studies. Hysteroscopic myomectomy is indicated for intracavitary 
myomas and submucous myomas having at least 50% of their volume within the uterine 
cavity. The management of the subfertile women with small intramural fibroids (<5 cm) is 
still a subject of debate (75,76). 
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